| Literature DB >> 32236824 |
Tamas Kiss1,2, Ádám Nyúl-Tóth1,3, Priya Balasubramanian1, Stefano Tarantini1,4,5, Chetan Ahire1, Jordan DelFavero1, Andriy Yabluchanskiy1,5, Tamas Csipo1,4,6, Eszter Farkas2, Graham Wiley7, Lori Garman7, Anna Csiszar8,9,10, Zoltan Ungvari1,2,4,5,11.
Abstract
Age-related phenotypic changes of cerebromicrovascular endothelial cells lead to dysregulation of cerebral blood flow and blood-brain barrier disruption, promoting the pathogenesis of vascular cognitive impairment (VCI). In recent years, endothelial cell senescence has emerged as a potential mechanism contributing to microvascular pathologies opening the avenue to the therapeutic exploitation of senolytic drugs in preclinical studies. However, difficulties with the detection of senescent endothelial cells in wild type mouse models of aging hinder the assessment of the efficiency of senolytic treatments. To detect senescent endothelial cells in the aging mouse brain, we analyzed 4233 cells in fractions enriched for cerebromicrovascular endothelial cells and other cells associated with the neurovascular unit obtained from young (3-month-old) and aged (28-month-old) C57BL/6 mice. We define 13 transcriptomic cell types by deep, single-cell RNA sequencing. We match transcriptomic signatures of cellular senescence to endothelial cells identified on the basis of their gene expression profile. Our study demonstrates that with advanced aging, there is an increased ratio of senescent endothelial cells (~ 10%) in the mouse cerebral microcirculation. We propose that our single-cell RNA sequencing-based method can be adapted to study the effect of aging on senescence in various brain cell types as well as to evaluate the efficiency of various senolytic regimens in multiple tissues.Entities:
Keywords: Aging; Blood-brain barrier; Geroscience; Senescence; Vascular cognitive impairment
Mesh:
Year: 2020 PMID: 32236824 PMCID: PMC7205992 DOI: 10.1007/s11357-020-00177-1
Source DB: PubMed Journal: Geroscience ISSN: 2509-2723 Impact factor: 7.713